Skip to main content
. 2021 May 22;49(5):03000605211012569. doi: 10.1177/03000605211012569

Figure 1.

Figure 1.

Study experimental approach. Schematic description of the primary endpoint: 1) adipose tissue components (measurement of cell size in histological sections; and infiltration of inflammatory cells, evaluated by immunofluorescence [IMF] of CD45+, CD68+ cells); and 2) related soluble pro-inflammatory and pro-oxidant mediators, as evaluated by immunoassays. As well as their putative association with the dynamic reduction of cardiovascular risk (CVR) after metabolic surgery, as estimated by change of endothelial dysfunction (measured by flow mediated dilation [FMD]) and subclinical atherogenesis (measured by carotid intima media thickness [CIMT]).